Benzinga | May 13, 2021 04:20PM EDT

Capricor Therapeutics Q1 EPS $(0.23) Up From $(0.30) YoY, Sales $40.82K Down From $185.69K YoY

Capricor Therapeutics (NASDAQ:CAPR) reported quarterly losses of $(0.23) per share. This is a 23.33 percent increase over losses of $(0.30) per share from the same period last year. The company reported $40.82 thousand in sales this quarter. This is a 78.02 percent decrease over sales of $185.69 thousand the same period last year.